Inhoudsopgave
Advertenties
Beschikbare talen
Beschikbare talen
It is clinically validated in patients with hypertension, hypotension,
diabetes, pregnancy, pre-eclampsia, atherosclerosis, end-stage
renal disease, obesity and the elderly.
The device can detect an irregular pulse suggestive of Atrial Fibril-
lation (AF). Please note that the device is not intended to diagnose
AF. A diagnosis of AF can only be confirmed by ECG. The patient
is advised to see a physician.
Dear Customer,
This device was developed in collaboration with physicians and clin-
ical tests carried out prove its measurement accuracy to be of a very
high standard.*
Microlife AFIBsens is the world's leading digital blood pressure
measurement technology for the detection of atrial fibrillation (AF)
and arterial hypertension. These are the two top risk factors of getting
a stroke or heart disease. It is important to detect AF and hyperten-
sion at an early stage, even though you may not experience any
symptoms. AF screening in general and thus also with the Microlife
AFIB algorithm, is recommended for people of 65 years and older.
The AFIB algorithm indicates that atrial fibrillation may be present.
For this reason, it is recommended that you visit your doctor when the
device gives an AFIB signal during your blood pressure measure-
ment. The AFIB algorithm of Microlife has been clinically investigated
by several prominent clinical investigators and showed that the
device detects patients with AFIB at a certainty of 97-100%.
If you have any questions, problems or want to order spare parts
please contact your local Microlife-Customer Service. Your dealer or
pharmacy will be able to give you the address of the Microlife dealer
in your country. Alternatively, visit the internet at www.microlife.com
where you will find a wealth of invaluable information on our products.
Stay healthy - Microlife Corporation!
* This device uses the same measuring technology as the award
winning «BP 3BTO-A» model tested according to the British and
Irish Hypertension Society (BIHS) protocol.
1
primary care: a diagnostic accuracy study comparing single-lead
ECG and modified BP monitors. BMJ Open 2014; 4:e004565.
2
Wiesel J, Arbesfeld B, Schechter D: Comparison of the Microlife
blood pressure monitor with the Omron blood pressure monitor for
detecting atrial fibrillation. Am J Cardiol 2014; 114:1046-1048.
2
Table of contents
1. Appearance of the Atrial Fibrillation Indicator for early
Detection (Active only in MAM mode)
What is Atrial Fibrillation (AF)?
Who should be screened for Atrial Fibrillation?
Risk factors you can control
1,2
Advertenties
Hoofdstukken
Inhoudsopgave
